SCHEMBL7694048

SCHEMBL7694048

O=c1nc(Nc2ccccc2)oc2cnccc12

nearest known ligand 0.71

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.71
▸ RAB9A P51151 3/20 0.71
▸ IDO1 P14902 5/20 0.55
▸ ALDH1A1 P00352 2/20 0.49
▸ ELANE P08246 2/20 0.49
▸ GAA P10253 1/20 0.49
▸ PKM P14618 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ TDO2 P48775 9/20 0.44
▸ LATS1 O95835 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13158929 0.83 RAB9A (1.00) NPC1RAB9AALDH1A1ELANEGAA
SCHEMBL3453705 0.77 ELANE (0.73) NPC1RAB9AALDH1A1ELANEGAA
SCHEMBL7694055 0.72 RAB9A (0.64) NPC1RAB9AALDH1A1ELANEGAA
SCHEMBL5489359 0.71 MEN1 (0.49) NPC1RAB9AIDO1ALDH1A1ELANE
SCHEMBL5963788 0.71 RAB9A (0.61) NPC1RAB9AALDH1A1ELANEGAA
SCHEMBL16247573 0.71 IDO1 (1.00) IDO1TDO2
SCHEMBL14228040 0.70 IDO1 (0.64) IDO1TDO2
SCHEMBL5821413 0.70 TDO2 (0.42) IDO1ALDH1A1ELANETDO2KDM4E
SCHEMBL5316896 0.68 ALDH1A1 (0.55) NPC1RAB9AALDH1A1GAASMN1; SMN2
SCHEMBL2658434 0.66 NPC1 (1.00) NPC1RAB9AALDH1A1ELANEGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000040569-A9 2-AMINO-BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF OBESITY ALIZYME THERAPEUTICS LTD (GB) 2002-02-28 — — WO claimed
Send feedback